PE20020903A1 - Metodo para prevenir la diarrea - Google Patents
Metodo para prevenir la diarreaInfo
- Publication number
- PE20020903A1 PE20020903A1 PE2001000284A PE2001000284A PE20020903A1 PE 20020903 A1 PE20020903 A1 PE 20020903A1 PE 2001000284 A PE2001000284 A PE 2001000284A PE 2001000284 A PE2001000284 A PE 2001000284A PE 20020903 A1 PE20020903 A1 PE 20020903A1
- Authority
- PE
- Peru
- Prior art keywords
- octreotide
- irinotecan
- administration
- refers
- prevent diarrhea
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/31—Somatostatins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/12—Antidiarrhoeals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Endocrinology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
SE REFIERE A UN METODO PARA PREVENIR LA DIARREA CAUSADA POR LA ADMINISTRACION DE IRINOTECAN O UNA SAL O UN METABOLITO FARMACEUTICAMENTE ACEPTABLE QUE COMPRENDE ADMINISTRAR A UN PACIENTE UNA CANTIDAD EFECTIVA DE UN OCTREOTIDO EN FORMA DE SAL ACETATO. EL OCTREOTIDO SE FORMULA EN UNA FORMA DE DOSIFICACION DE LIBERACION CON ACCION PROLONGADA. SE REFIERE TAMBIEN A FORMULACIONES DE COMBINACION Y A KITS PARA PREVENIR LA DIARREA PROVOCADA POR EL IRINOTECAN O LA ADMINISTRACION DE UN ANALOGO DE CAMPTOTECINA
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US09/450,201 US6159935A (en) | 1999-11-29 | 1999-11-29 | Method for preventing diarrhea |
Publications (1)
Publication Number | Publication Date |
---|---|
PE20020903A1 true PE20020903A1 (es) | 2002-10-23 |
Family
ID=23787180
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PE2001000284A PE20020903A1 (es) | 1999-11-29 | 2001-03-27 | Metodo para prevenir la diarrea |
Country Status (6)
Country | Link |
---|---|
US (2) | US6159935A (es) |
AR (1) | AR026606A1 (es) |
AU (1) | AU3439301A (es) |
CO (1) | CO5271647A1 (es) |
PE (1) | PE20020903A1 (es) |
WO (1) | WO2001037784A2 (es) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20060205681A1 (en) * | 2002-06-21 | 2006-09-14 | Maryam Moaddeb | Homogenous paste formulations |
AU2003259220C1 (en) | 2002-07-24 | 2017-08-24 | Australian Health & Nutrition Association Limited | Compositions and products containing enantiomeric equol, and methods for their making |
ES2383303T3 (es) | 2005-11-10 | 2012-06-20 | Chemi S.P.A. | Formulaciones de inhibidores de la liberación prolongada de la hormona del crecimiento análogos de la somatostatina |
NZ591810A (en) | 2008-09-17 | 2012-12-21 | Chiasma Inc | Pharmaceutical compositions and related methods of delivery the composition comprises a medium chain fatty acid |
CA2975599A1 (en) | 2015-02-03 | 2016-08-11 | Chiasma Inc. | Method of treating diseases |
CA3011982A1 (en) * | 2016-01-21 | 2017-07-27 | Chiasma Inc. | Oral octreotide for the treatment of disease |
US11141457B1 (en) | 2020-12-28 | 2021-10-12 | Amryt Endo, Inc. | Oral octreotide therapy and contraceptive methods |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CY1327A (en) * | 1979-11-27 | 1986-06-27 | Sandoz Ag | Novel polypeptides,processes for their production,pharmaceutical compositions comprising said polypeptides and their use |
US4473692A (en) * | 1981-09-04 | 1984-09-25 | Kabushiki Kaisha Yakult Honsha | Camptothecin derivatives and process for preparing same |
JPS6019790A (ja) * | 1983-07-14 | 1985-01-31 | Yakult Honsha Co Ltd | 新規なカンプトテシン誘導体 |
PH30995A (en) | 1989-07-07 | 1997-12-23 | Novartis Inc | Sustained release formulations of water soluble peptides. |
US5786344A (en) * | 1994-07-05 | 1998-07-28 | Arch Development Corporation | Camptothecin drug combinations and methods with reduced side effects |
US5789411A (en) | 1995-09-11 | 1998-08-04 | Lance L. Gooberman P. C. | Improvements to rapid opioid detoxification |
US5919760A (en) | 1996-04-12 | 1999-07-06 | Intensive Narcotic Detoxification Centers Of America, Llc | Method for treating acute and severe diarrhea |
WO1998037892A1 (en) | 1997-02-27 | 1998-09-03 | Pharmacia & Upjohn Company | Tamoxifen as a therapy to reduce irinotecan hydrochloride-induced diarrhea |
-
1999
- 1999-11-29 US US09/450,201 patent/US6159935A/en not_active Expired - Fee Related
-
2000
- 2000-08-25 US US09/648,270 patent/US6395708B1/en not_active Expired - Fee Related
- 2000-11-13 AU AU34393/01A patent/AU3439301A/en not_active Abandoned
- 2000-11-13 WO PCT/US2000/042136 patent/WO2001037784A2/en active Application Filing
- 2000-11-27 AR ARP000106218A patent/AR026606A1/es unknown
- 2000-11-27 CO CO00090627A patent/CO5271647A1/es not_active Application Discontinuation
-
2001
- 2001-03-27 PE PE2001000284A patent/PE20020903A1/es not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
US6159935A (en) | 2000-12-12 |
AU3439301A (en) | 2001-06-04 |
WO2001037784A2 (en) | 2001-05-31 |
AR026606A1 (es) | 2003-02-19 |
WO2001037784A3 (en) | 2002-05-10 |
US6395708B1 (en) | 2002-05-28 |
CO5271647A1 (es) | 2003-04-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR0115382A (pt) | Formulações para liberação controlada de hidrocodona, método de produzir analgesia efetiva, processo de preparação de uma forma farmacêutica de um sólido oral de liberação controlada, liberação controlada da forma farmacêutica oral e uso da forma farmacêutica | |
BRPI0015567B8 (pt) | composto, composição farmacêutica, forma de unidade de dosagem, uso da composição farmacêutica e método para preparar uma composição farmacêutica | |
ECSP034620A (es) | Mezclas o compuestos organicos para el tratamiento de enfermedades de las vias respiratorias | |
AR022254A1 (es) | Composicion de administracion oral. | |
NZ514574A (en) | Novel method of treatment | |
UY26635A1 (es) | Métodos sinérgicos y composiciones para el tratamiento del cáncer | |
EA200700049A1 (ru) | Препаративные формы оральных лекарственных форм мемантина с модифицированным высвобождением | |
CL2009001682A1 (es) | Composición farmacéutica espontáneamente dispersable para administración oral que comprende n-benzoil-estaurosporina; método para incrementar los niveles de biodisponibilidad. (divisional de la solocitud 333-00). | |
CO4970819A1 (es) | Tratamiento de disfuncion sexual femenina en una hembra humana | |
ES2170069T3 (es) | 1-alfa-hidroxiprevitamina d para administracion oral. | |
AR050463A1 (es) | Analagos de lonidamina y su uso en anticoncepcion masculina y en el tratamiento contra el cancer. | |
MXPA04003608A (es) | Composiciones inyectables para el suministro controlado de compuesto farmacologicamente activo. | |
AR020803A1 (es) | Una composicion que comprende fexofenadina o una sal farmaceuticamente aceptable de la misma y el uso de la misma para la manufactura de unmedicamento | |
AR033688A1 (es) | Composicion parenteral reconstituible | |
CO5280073A1 (es) | Composiciones | |
BR0207872A (pt) | Composto para liberar agentes ativos, composição, forma de unidade de dosagem e método de administração | |
AR021912A1 (es) | Uso de apomorfina para el tratamiento de la disfuncion erectil organica en varones | |
AR030039A1 (es) | Composicion farmaceutica que comprende una droga inhibidora selectiva de la ciclooxigenasa-2, su uso en la fabricacion de un medicamento para tratar o prevenir afecciones mediadas por la ciclooxigenasa-2 y metodo para hacer dicho medicamento | |
BR0114100A (pt) | Formulações de liberação controlada para administração oral | |
AR029373A1 (es) | Metodo para el tratamiento de migranas, utilizando compuestos antagonistas selectivos de los receptores iglur5, uso de dichos compuestos antagonistas selectivos en la manufactura de medicamentos para el tratamiento de migranas y dichos compuestos antagonistas | |
PA8542901A1 (es) | Uso de (z)-2-ciano-3-hidroxi-but-2-acido enoico-(4-trifluorometilfenil)-amida para tratar la esclerosis multiple | |
ECSP066318A (es) | Composición para la liberación de una base debil por un periodo extendido de tiempo | |
ATE268174T1 (de) | Sibutramin und orlistat enthaltende pharmazeutische zusammensetzungen | |
PE20020903A1 (es) | Metodo para prevenir la diarrea | |
AR046410A1 (es) | Composiciones farmaceuticas para la liberacion modificada de modafinilo |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FA | Abandonment or withdrawal |